255 related articles for article (PubMed ID: 1602514)
41. [Hepatorenal syndrome].
Radziszewski A; Sułowicz W
Przegl Lek; 2006; 63(7):573-8. PubMed ID: 17203812
[TBL] [Abstract][Full Text] [Related]
42. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
[TBL] [Abstract][Full Text] [Related]
43. [Endogenous digitalis-like factor in liver cirrhosis and cholestasis].
Behrens R; Glauck D; Kaltenborn G; Behrens B; Wache H; Schlee H; Rink C; Böhme I; Nilius R
Z Gastroenterol; 1993 Feb; 31 Suppl 2():20-3. PubMed ID: 7483706
[TBL] [Abstract][Full Text] [Related]
44. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
Karwa R; Woodis CB
Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
[TBL] [Abstract][Full Text] [Related]
45. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
46. [Hepatorenal syndrome: terminal stage of major complicances of hepatic cirrhosis].
Costantino S
Clin Ter; 2004 Sep; 155(9):361-2. PubMed ID: 15700628
[No Abstract] [Full Text] [Related]
47. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.
Wong F; Nadim MK; Kellum JA; Salerno F; Bellomo R; Gerbes A; Angeli P; Moreau R; Davenport A; Jalan R; Ronco C; Genyk Y; Arroyo V
Gut; 2011 May; 60(5):702-9. PubMed ID: 21325171
[TBL] [Abstract][Full Text] [Related]
48. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis.
Vlachogiannakos J; Viazis N; Vasianopoulou P; Vafiadis I; Karamanolis DG; Ladas SD
J Gastroenterol Hepatol; 2013 Mar; 28(3):450-5. PubMed ID: 23216382
[TBL] [Abstract][Full Text] [Related]
49. Pathogenesis and management of the hepatorenal syndrome.
Laffi G; La Villa G; Gentilini P
Semin Liver Dis; 1994 Feb; 14(1):71-81. PubMed ID: 8016664
[No Abstract] [Full Text] [Related]
50. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
Wiegand J; Kühne M; Pradat P; Mössner J; Trepo C; Tillmann HL
Aliment Pharmacol Ther; 2012 Jun; 35(12):1443-50. PubMed ID: 22530565
[TBL] [Abstract][Full Text] [Related]
51. Pathophysiology and treatment of hepatorenal syndrome.
Wong F; Blendis L
Gastroenterologist; 1998 Jun; 6(2):122-35. PubMed ID: 9660529
[TBL] [Abstract][Full Text] [Related]
52. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt.
Spahr L; Fenyves D; N'Guyen VV; Roy L; Legault L; Dufresne MP; Pomier-Layrargues G
Am J Gastroenterol; 1995 Jul; 90(7):1169-71. PubMed ID: 7611221
[TBL] [Abstract][Full Text] [Related]
53. The management and nursing care of cirrhotic ascites.
Sargent S
Br J Nurs; 2006 Feb 23-Mar 8; 15(4):212-9. PubMed ID: 16603988
[TBL] [Abstract][Full Text] [Related]
54. Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
Møller S; Aagaard NK; Schmidt L; Grønbaek H; Hansen JB; Bendtsen F
Dan Med J; 2012 Jan; 59(1):C4372. PubMed ID: 22239848
[TBL] [Abstract][Full Text] [Related]
55. [Hepato-renal insufficiency in food poisoning in patients with alcoholic liver cirrhosis].
Brodov LE; Karetkina GN; Iushchuk ND; Maleev VV
Klin Med (Mosk); 1985 Jul; 63(7):82-5. PubMed ID: 4046542
[No Abstract] [Full Text] [Related]
56. Improvement of renal failure with repeated head-out water immersions in patients with hepatorenal syndrome associated with alcoholic hepatitis.
Yersin B; Burnier M; Magnenat P
Am J Nephrol; 1995; 15(3):260-5. PubMed ID: 7618653
[TBL] [Abstract][Full Text] [Related]
57. Calciphylaxis associated with acute, reversible renal failure in the setting of alcoholic cirrhosis.
Chavel SM; Taraszka KS; Schaffer JV; Lazova R; Schechner JS
J Am Acad Dermatol; 2004 May; 50(5 Suppl):S125-8. PubMed ID: 15097947
[TBL] [Abstract][Full Text] [Related]
58. [Renal dysfunction in liver disease].
Dylewska M; Wieliczko M
Wiad Lek; 2015; 68(4 Pt 2):631-3. PubMed ID: 27162299
[TBL] [Abstract][Full Text] [Related]
59. Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: evidence for a nonfunctional mechanism of hepatorenal syndrome.
Arroyo V
Hepatol Int; 2017 May; 11(3):242-244. PubMed ID: 28124314
[No Abstract] [Full Text] [Related]
60. Hepatocirculatory failure: diverse pathogeneses deserve diverse therapies.
Cohn JN
Hepatology; 1990 Mar; 11(3):510-1. PubMed ID: 2312065
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
